fertility preservation in cancer patients: in vivo and in vitro options

Authors

rouhollah fathi

mojtaba rezazadeh valojerdi

bita ebrahimi

farideh eivazkhani

abstract

oocyte, embryo and ovarian tissue cryopreservation are being increasingly proposed for fertility preservation among cancer patients undergoing therapy to enable them to have babies after the cancer is cured. embryo cryopreservation is not appropriate for single girls without any sperm partner and also because oocyte retrieval is an extended procedure, it is impossible in cases requiring immediate cancer cure. thus ovarian tissue cryopreservation has been suggested for fertility preservation especial in cancer patients. the main goal of ovarian cryopreservation is re-implanting the tissue into the body to restore fertility and the hormonal cycle. different cryopreservation protocols have been examined and established for vitrification of biological samples. we have used cryopin to plunge ovarian tissue into the liquid nitrogen and promising results have been observed. ovarian tissue re-implantation after cancer cure has one problem- the possibility of recurrence of malignancy in the reimplanted tissue is high. xenografting-implantation of the preserved tissue in another species-also has its drawbacks such as molecular signaling from the recipient. in vitro follicle culturing is a safer method to obtain mature oocytes for fertilization and the various studies that have been carried out in this area are reviewed in this paper.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Fertility Preservation in Cancer Patients: In Vivo and In Vitro Options.

Oocyte, embryo and ovarian tissue cryopreservation are being increasingly proposed for fertility preservation among cancer patients undergoing therapy to enable them to have babies after the cancer is cured. Embryo cryopreservation is not appropriate for single girls without any sperm partner and also because oocyte retrieval is an extended procedure, it is impossible in cases requiring immedia...

full text

I-22: Fertility Preservation and Ovarian Stimulation in Cancer Patients

Cancer is not uncommon and no longer considered to be an incurable disorder. 10% of cancer cases occur under the age of 45. There is a remarkable improvement in treatment and survival rates. Today women have been delaying initiation of childbearing because the incidence of most cancers increases with age. Delayed childbearing results in more female cancer survivors. As a consequence there is an...

full text

I-12: Optimal Strategy toward Fertility Preservation: In Vivo and In Vitro Post-Thaw Options in Gamete, Embryo and Ovarian Tissue Cryostorage

Background: Oocyte, embryo and ovarian tissue cryopreservation are proposed for fertility preservation to cancer patients who hope to be mothers after getting rid of the disease. Materials and Methods: Embryo cryopreservation is not possible for unmarried single girls without sperm partner and oocyte retrieval is a long time procedure. Thus ovarian tissue cryopreservation is suggested for ferti...

full text

Fertility Preservation Options for Cancer Patients

The number of reported new cancer cases is increasing every year. The probability of surviving cancer is high and is continually improving. The cancer treatment may induce ovarian or testicular failure by damaging ovarian follicles in females and spermatogonia in the males. Gonadal failure may affect all aspects of reproductive health, including pubertal development, hormone production, and sex...

full text

My Resources

Save resource for easier access later


Journal title:
cell journal

جلد ۱۹، شماره ۲، صفحات ۱۷۳-۱۸۳

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023